Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(40.0%)
Phase 1
2(40.0%)
Phase 2
1(20.0%)
5Total
N/A(2)
Phase 1(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04255498Phase 1Unknown

Understanding GWI: Integrative Modeling

Role: lead

NCT02848417Phase 1Unknown

Glutathione vs. Curcumin Clinical Trial

Role: lead

NCT00013078Not ApplicableCompleted

Safe-Grip Fall/Injuries Intervention: A Randomized Trial

Role: collaborator

NCT01417806Phase 2Unknown

Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer

Role: lead

NCT01307137Not ApplicableUnknown

Peer-led and Telehealth Comparative Effectiveness Research (CER) Adoption for Diabetes Prevention and Management

Role: lead

All 5 trials loaded